{"id":"control-ipv","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Irritability or fussiness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains chemically inactivated (killed) poliovirus particles that cannot cause disease but trigger a protective immune response. Upon administration, the immune system recognizes these viral antigens and generates neutralizing antibodies and cellular immunity against poliovirus. This immunity prevents infection and disease if the vaccinated individual is exposed to wild-type poliovirus.","oneSentence":"Control IPV is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:07:37.140Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Poliomyelitis prevention in infants and children"}]},"trialDetails":[{"nctId":"NCT07473856","phase":"NA","title":"Long-term Use of Intrapulmonary Percussive Ventilation for Preventing Hospitalizations Due to Respiratory Decompensation in Children With Multiple Disabilities","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03","conditions":"Respiratory Decompensation, Multiple Disabilities","enrollment":146},{"nctId":"NCT07457060","phase":"PHASE4","title":"Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine","status":"RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2025-11-27","conditions":"Poliomyelitis","enrollment":480},{"nctId":"NCT07453966","phase":"NA","title":"Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation","status":"NOT_YET_RECRUITING","sponsor":"Zhongnan Hospital","startDate":"2026-03-01","conditions":"Pneumonia","enrollment":96},{"nctId":"NCT06975878","phase":"PHASE3","title":"Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-05-22","conditions":"Pneumococcal Immunization, Healthy Volunteers","enrollment":1092},{"nctId":"NCT05490004","phase":"NA","title":"RISE With Veteran Service Providers","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-08-01","conditions":"Domestic Violence, Veterans Family, Veterans","enrollment":40},{"nctId":"NCT06414070","phase":"NA","title":"Developing and Testing the Jenga Dada Intervention in Kenya","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2024-06-17","conditions":"Reproductive Coercion, Intimate Partner Violence","enrollment":238},{"nctId":"NCT06736041","phase":"PHASE3","title":"Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-12-18","conditions":"Pneumococcal Immunization","enrollment":1714},{"nctId":"NCT06783400","phase":"NA","title":"What Works - Malawi SASA! Together","status":"RECRUITING","sponsor":"George Washington University","startDate":"2024-08-27","conditions":"Intimate Partner Violence (IPV), Norms, Social, Gender Inequitable Behavior","enrollment":4800},{"nctId":"NCT07405528","phase":"NA","title":"Camouflaged WeChat-based Intervention for Abused Women","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-02","conditions":"Domestic Violence, Mental Health Wellness 1","enrollment":86},{"nctId":"NCT06750107","phase":"PHASE3","title":"Testing the Efficacy of Safe South Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brown University","startDate":"2025-01-22","conditions":"Intervention, Control","enrollment":836},{"nctId":"NCT05644184","phase":"PHASE2","title":"Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh","status":"RECRUITING","sponsor":"PATH","startDate":"2023-03-27","conditions":"Poliomyelitis","enrollment":2232},{"nctId":"NCT03891758","phase":"PHASE3","title":"Confirmatory Study of BK1310 in Healthy Infants","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2019-04-01","conditions":"Tetanus, Diphtheria, Pertussis","enrollment":267},{"nctId":"NCT07297992","phase":"NA","title":"The Effect of Simulation Training on Nursing Students' Perception, Myths and Attitudes of Dating Violence","status":"ENROLLING_BY_INVITATION","sponsor":"Abant Izzet Baysal University","startDate":"2025-12-01","conditions":"Nursing Students, Intimate Partner Violence (IPV)","enrollment":90},{"nctId":"NCT07297186","phase":"PHASE3","title":"Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)","status":"COMPLETED","sponsor":"Beijing Minhai Biotechnology Co., Ltd","startDate":"2017-08-21","conditions":"Poliomyelitis","enrollment":1200},{"nctId":"NCT05850364","phase":"PHASE3","title":"A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2023-05-22","conditions":"Poliomyelitis, Polio","enrollment":1442},{"nctId":"NCT07226401","phase":"NA","title":"Virtual Village for Young Parents","status":"RECRUITING","sponsor":"RTI International","startDate":"2025-11-11","conditions":"Gender-based Violence, Intimate Partner Violence","enrollment":80},{"nctId":"NCT06811922","phase":"NA","title":"The Primary Prevention of Intimate Partner Violence","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Intimate Partner Violence","enrollment":1700},{"nctId":"NCT07165860","phase":"NA","title":"Clinical Trial to Reduce Perinatal Intimate Partner Violence","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-11-01","conditions":"Domestic Violence, Perinatal Problems","enrollment":326},{"nctId":"NCT05366387","phase":"NA","title":"Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2022-11-23","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":9},{"nctId":"NCT05287711","phase":"NA","title":"Adjunctive Motivational Alcohol Intervention to Prevent IPV","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-09-01","conditions":"Alcohol Use and Intimate Partner Violence","enrollment":300},{"nctId":"NCT06001307","phase":"NA","title":"Supporting Trans Affirmation, Relationships, and Sex, Phase 3","status":"COMPLETED","sponsor":"Brown University","startDate":"2023-06-20","conditions":"HIV, Violence, Gender-Based, Violence, Domestic","enrollment":37},{"nctId":"NCT06331156","phase":"PHASE3","title":"A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-03-22","conditions":"Gastroenteritis","enrollment":400},{"nctId":"NCT07218159","phase":"NA","title":"Can the IDEA3 Intervention Prevent Intimate Partner Violence?: A Substudy to the IDEA3 Randomized Controlled Trial","status":"ENROLLING_BY_INVITATION","sponsor":"University of Maryland, College Park","startDate":"2025-09-29","conditions":"Intimate Partner Violence (IPV)","enrollment":289},{"nctId":"NCT07213089","phase":"PHASE2, PHASE3","title":"Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers","status":"COMPLETED","sponsor":"BioNet-Asia Co., Ltd.","startDate":"2020-07-13","conditions":"Pertussis Whooping Cough","enrollment":290},{"nctId":"NCT05490121","phase":"NA","title":"RISE With Residents","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-08-01","conditions":"Domestic Violence, Child Maltreatment, Pediatric ALL","enrollment":71},{"nctId":"NCT04429295","phase":"PHASE3","title":"Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-06-28","conditions":"Pertussis Immunisation, Diphtheria Immunisation, Polio Immunisation","enrollment":460},{"nctId":"NCT05599581","phase":"NA","title":"Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"RTI International","startDate":"2022-09-29","conditions":"IPV, HIV, PrEP","enrollment":1562},{"nctId":"NCT05331248","phase":"NA","title":"Training Local Leaders to Prevent and Reduce Domestic Violence Evidence From Peru","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-05-02","conditions":"Domestic Violence","enrollment":8754},{"nctId":"NCT05614492","phase":"NA","title":"Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2023-05-10","conditions":"HIV, Violence, Gender-Based, Pre-Exposure Prophylaxis","enrollment":53},{"nctId":"NCT06879327","phase":"PHASE2","title":"Infant Malaria Vaccine Schedule Optimization","status":"RECRUITING","sponsor":"PATH","startDate":"2025-05-30","conditions":"Malaria Vaccines","enrollment":1200},{"nctId":"NCT06074068","phase":"NA","title":"Father-Focused Intervention for Reducing Family Violence and Symptoms in Children","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-01-11","conditions":"Intimate Partner Violence, Child Maltreatment","enrollment":1080},{"nctId":"NCT07010822","phase":"PHASE3","title":"A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants","status":"NOT_YET_RECRUITING","sponsor":"Fidec Corporation","startDate":"2025-12-08","conditions":"Poliomyelitis","enrollment":740},{"nctId":"NCT05893277","phase":"NA","title":"Harmony: A Combined MI and BCT Intervention to Reduce Intimate Partner Violence and Alcohol Use in South India","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-10-12","conditions":"Intimate Partner Violence, Alcohol Use Disorder","enrollment":800},{"nctId":"NCT06577298","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers","status":"RECRUITING","sponsor":"CanSino Biologics Inc.","startDate":"2024-12-19","conditions":"Poliomyelitis","enrollment":480},{"nctId":"NCT06947499","phase":"PHASE2, PHASE3","title":"A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series","status":"RECRUITING","sponsor":"LG Chem","startDate":"2025-05-30","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":1186},{"nctId":"NCT03179982","phase":"NA","title":"Integrated Prevention of HIV Risk and Intimate Partner Violence Among Adolescents in South Africa","status":"COMPLETED","sponsor":"Brown University","startDate":"2019-02-01","conditions":"Sexual Behavior, Intimate Partner Violence","enrollment":60},{"nctId":"NCT06834867","phase":"NA","title":"Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal","status":"RECRUITING","sponsor":"Possible","startDate":"2025-04-04","conditions":"Intimate Partner Violence (IPV), Depression, PTSD - Post Traumatic Stress Disorder","enrollment":900},{"nctId":"NCT03614533","phase":"PHASE2","title":"Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2018-12-03","conditions":"Typhoid","enrollment":251},{"nctId":"NCT06853314","phase":"NA","title":"An Effectiveness Trial of the PrEP for WINGS Study","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2025-04","conditions":"HIV Infections, Alcohol Use Disorder, Violence, Gender-Based","enrollment":""},{"nctId":"NCT06350383","phase":"NA","title":"Adapting a Low-cost Intimate Partner Violence and Mental Health Response Intervention","status":"COMPLETED","sponsor":"Columbia University","startDate":"2024-05-21","conditions":"Violence, Domestic, Psychological Distress","enrollment":260},{"nctId":"NCT06934174","phase":"PHASE2","title":"Cultural Adaptation of a Web-Based App (myPlan Thailand) to Empower and Support Friends and Family of Intimate Partner Violence Survivors","status":"RECRUITING","sponsor":"Boromarajonani College of Nursing, Khon Kaen","startDate":"2025-04-17","conditions":"Intimate Partner Violence (IPV), Social Support, Empowerment","enrollment":100},{"nctId":"NCT06803043","phase":"NA","title":"Evaluation of a Trauma-Informed Partner Violence Intervention Program","status":"ENROLLING_BY_INVITATION","sponsor":"Boston University","startDate":"2025-02-13","conditions":"Domestic Violence, Post Traumatic Stress Disorder","enrollment":800},{"nctId":"NCT06942481","phase":"EARLY_PHASE1","title":"Evaluating Girls Invest: A Mobile-Enabled Economic Empowerment Intervention for Girls to Reduce Risk for Partner Violence","status":"COMPLETED","sponsor":"San Diego State University","startDate":"2022-09-07","conditions":"Risk Factors for Intimate Partner Violence","enrollment":240},{"nctId":"NCT05608421","phase":"NA","title":"1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-06-26","conditions":"Violence, Domestic, HIV, Stigma, Social","enrollment":100},{"nctId":"NCT06916377","phase":"NA","title":"The Economics of Domestic Violence: Evidence From Bangladesh","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-09-19","conditions":"Intimate Partner Violence (IPV), Intimate Partner Violence Prevention","enrollment":440},{"nctId":"NCT06903221","phase":"PHASE4","title":"A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human Infection","status":"RECRUITING","sponsor":"Dimitri Diavatopoulos","startDate":"2024-10-16","conditions":"Pertussis Infection, Pertussis Vaccines","enrollment":99},{"nctId":"NCT05951725","phase":"PHASE3","title":"A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"CanSino Biologics Inc.","startDate":"2023-08-11","conditions":"Diphtheria, Tetanus and Acellular Pertussis","enrollment":2520},{"nctId":"NCT05129501","phase":"NA","title":"The Impact of an Adapted Version of the Strengthening Families Program on IPV Among Caregivers and ACEs Among Children","status":"COMPLETED","sponsor":"University of Nebraska Lincoln","startDate":"2021-10-09","conditions":"Adverse Childhood Experiences, Domestic Violence","enrollment":318},{"nctId":"NCT03566940","phase":"PHASE2","title":"A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule","status":"COMPLETED","sponsor":"Janssen Vaccines & Prevention B.V.","startDate":"2018-07-31","conditions":"Healthy","enrollment":302},{"nctId":"NCT06454812","phase":"NA","title":"The Effect of Mechanical Vibration and Helfer Skin Tap Technique on Procedural Pain in Infants During Vaccination","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2024-07-15","conditions":"Procedural Pain, Nursing Caries, Pain, Acute","enrollment":108},{"nctId":"NCT06768502","phase":"NA","title":"Effectiveness of Community-based Approach in Reducing the Intimate Partner Violence (IPV) Exposure and Outcome","status":"COMPLETED","sponsor":"University of Rwanda","startDate":"2020-02-18","conditions":"Intimate Partner Violence (IPV), Anxiety, Depression","enrollment":62},{"nctId":"NCT06752174","phase":"PHASE3","title":"A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants","status":"COMPLETED","sponsor":"Beijing Minhai Biotechnology Co., Ltd","startDate":"2023-03-08","conditions":"Poliomyelitis","enrollment":300},{"nctId":"NCT06748612","phase":"PHASE4","title":"Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)","status":"NOT_YET_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2025-01-28","conditions":"Polio","enrollment":1190},{"nctId":"NCT06101173","phase":"PHASE1","title":"A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults","status":"COMPLETED","sponsor":"CanSino Biologics Inc.","startDate":"2024-01-15","conditions":"Poliomyelitis","enrollment":72},{"nctId":"NCT04529538","phase":"PHASE1","title":"Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines","status":"COMPLETED","sponsor":"PATH","startDate":"2021-03-26","conditions":"Poliomyelitis","enrollment":226},{"nctId":"NCT06690515","phase":"PHASE1, PHASE2","title":"Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants","status":"NOT_YET_RECRUITING","sponsor":"PT Bio Farma","startDate":"2025-03-01","conditions":"Vaccine Adverse Reaction, Vaccine Reaction","enrollment":465},{"nctId":"NCT03537508","phase":"PHASE3","title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-04-25","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":2627},{"nctId":"NCT06618196","phase":"PHASE2","title":"Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age","status":"NOT_YET_RECRUITING","sponsor":"LG Chem","startDate":"2024-10-02","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":336},{"nctId":"NCT06605755","phase":"NA","title":"Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants","status":"RECRUITING","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2024-09-05","conditions":"Pertussis, Diphtheria, Tetanus","enrollment":785},{"nctId":"NCT06413121","phase":"PHASE3","title":"Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV","status":"RECRUITING","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2024-05-06","conditions":"Diptheria Immunization, Tetanus Immunization, Pertussis Immunization","enrollment":1557},{"nctId":"NCT04535037","phase":"PHASE4","title":"A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-05-26","conditions":"Diphtheria","enrollment":500},{"nctId":"NCT02961595","phase":"PHASE1","title":"Live Enterovirus Vaccine and Type 1 Diabetes","status":"COMPLETED","sponsor":"Tampere University","startDate":"1999-10","conditions":"Enterovirus Infection, Type 1 Diabetes, Prediabetic State","enrollment":315},{"nctId":"NCT00137696","phase":"NA","title":"Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2003-07","conditions":"Poliomyelitis","enrollment":473},{"nctId":"NCT05388565","phase":"NA","title":"Domestic Violence Enhanced Perinatal Care Program in China","status":"RECRUITING","sponsor":"University of Texas at Austin","startDate":"2023-02-25","conditions":"Intimate Partner Violence","enrollment":100},{"nctId":"NCT05386810","phase":"PHASE3","title":"Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2020-11-05","conditions":"Poliomyelitis","enrollment":1572},{"nctId":"NCT04165291","phase":"NA","title":"Comparing a Fatherhood Focused Individual Intervention to Batterer Intervention to Reduce IPV and Child Maltreatment","status":"COMPLETED","sponsor":"Yale University","startDate":"2020-09-01","conditions":"Intimate Partner Violence","enrollment":60},{"nctId":"NCT06344065","phase":"PHASE3","title":"Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants","status":"RECRUITING","sponsor":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","startDate":"2023-12-21","conditions":"Healthy Volunteers","enrollment":1584},{"nctId":"NCT04235335","phase":"NA","title":"Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2024-02-23","conditions":"Violence, Domestic","enrollment":160},{"nctId":"NCT06284148","phase":"NA","title":"Confidential IPV Screening Tool","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2010-10-06","conditions":"Violence, Domestic","enrollment":19655},{"nctId":"NCT05654467","phase":"PHASE2","title":"Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama","status":"UNKNOWN","sponsor":"PATH","startDate":"2023-12-05","conditions":"Poliomyelitis","enrollment":1532},{"nctId":"NCT06213506","phase":"PHASE2","title":"A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-01-15","conditions":"Salmonella Infections","enrollment":516},{"nctId":"NCT06184542","phase":"PHASE1","title":"Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine","status":"RECRUITING","sponsor":"Institute of Medical Biology, Chinese Academy of Medical Sciences","startDate":"2023-12-23","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":460},{"nctId":"NCT03885349","phase":"NA","title":"Motivational Strategies in Batterer Intervention Programs for Offenders With Alcohol/Drug Abuse Problems (IMP-ADAPs)","status":"UNKNOWN","sponsor":"University of Valencia","startDate":"2019-03-04","conditions":"Intimate Partner Violence Against Women, Alcohol Abuse, Drug Abuse","enrollment":80},{"nctId":"NCT05163561","phase":"PHASE3","title":"Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2022-01-09","conditions":"Poliomyelitis","enrollment":1072},{"nctId":"NCT05331508","phase":"NA","title":"Testing Gender-based Violence Response in Family Planning and Antenatal Care Services in Nigeria","status":"COMPLETED","sponsor":"Jhpiego","startDate":"2022-04-06","conditions":"Gender-based Violence, Reproductive Coercion, Intimate Partner Violence","enrollment":1756},{"nctId":"NCT03261700","phase":"NA","title":"Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2018-10-22","conditions":"Intimate Partner Violence, Self-efficacy","enrollment":60},{"nctId":"NCT05952596","phase":"PHASE1","title":"A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults","status":"UNKNOWN","sponsor":"LG Chem","startDate":"2023-07-17","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":42},{"nctId":"NCT05011552","phase":"NA","title":"Feasibility Study for Abused Chinese Immigrant Women","status":"COMPLETED","sponsor":"University of Texas at Austin","startDate":"2022-03-01","conditions":"Intimate Partner Violence, Depression, Anxiety","enrollment":50},{"nctId":"NCT05457946","phase":"PHASE2, PHASE3","title":"Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series","status":"UNKNOWN","sponsor":"LG Chem","startDate":"2023-04-01","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":1438},{"nctId":"NCT03534401","phase":"NA","title":"Addressing Reproductive Coercion in HEalth Settings - Kenya","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-06-01","conditions":"Unintended Pregnancy, Family Planning, Intimate Partner Violence (IPV)","enrollment":659},{"nctId":"NCT04092114","phase":"NA","title":"CHARISMA Expansion Study","status":"COMPLETED","sponsor":"RTI International","startDate":"2018-10-15","conditions":"Relationship Dynamics, Pre-exposure Prophylaxis (PrEP) Adherence","enrollment":407},{"nctId":"NCT04989231","phase":"","title":"An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2021-09-09","conditions":"Poliomyelitis","enrollment":450},{"nctId":"NCT04978064","phase":"NA","title":"E-health Psychological Intervention in Pregnant Women Exposed to Intimate Partner Violence (eIPV)","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2021-10-07","conditions":"Pregnancy Related, Violence, Gender-Based, Intimate Partner Violence","enrollment":24},{"nctId":"NCT05674591","phase":"NA","title":"Cognitive Processing Therapy in Syrian Women Exposed to IPV","status":"COMPLETED","sponsor":"British University In Egypt","startDate":"2021-01-05","conditions":"Depression, Anxiety, PTSD","enrollment":30},{"nctId":"NCT04099303","phase":"PHASE1","title":"Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .","status":"COMPLETED","sponsor":"CanSino Biologics Inc.","startDate":"2020-04-28","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":400},{"nctId":"NCT04054882","phase":"PHASE4","title":"Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP","status":"COMPLETED","sponsor":"China National Biotec Group Company Limited","startDate":"2019-08-16","conditions":"Vaccination","enrollment":702},{"nctId":"NCT02447718","phase":"PHASE4","title":"Vaccinating Children After Chemotherapy","status":"COMPLETED","sponsor":"Canadian Immunization Research Network","startDate":"2015-11-16","conditions":"Acute Lymphoblastic Leukemia","enrollment":156},{"nctId":"NCT04142814","phase":"NA","title":"Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients","status":"WITHDRAWN","sponsor":"Montecatone Rehabilitation Institute S.p.A.","startDate":"2022-02","conditions":"Spinal Cord Injury Cervical","enrollment":""},{"nctId":"NCT02274285","phase":"PHASE3","title":"DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2014-10","conditions":"Tetanus, Diphtheria, Pertussis","enrollment":424},{"nctId":"NCT01049035","phase":"PHASE2","title":"A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-12-16","conditions":"Meningitis, Meningococcal Infection","enrollment":580},{"nctId":"NCT04544787","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates","status":"COMPLETED","sponsor":"Pierre Van Damme","startDate":"2018-10-22","conditions":"Poliomyelitis","enrollment":250},{"nctId":"NCT01661504","phase":"NA","title":"Evaluating Violence Against Women Screening in Mexico","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-03","conditions":"Domestic Violence","enrollment":959},{"nctId":"NCT03539315","phase":"NA","title":"Adaptation and Testing of the Addressing Reproductive Coercion in HEalth Settings (ARCHES) Intervention in Bangladesh","status":"COMPLETED","sponsor":"Ipas","startDate":"2019-01-28","conditions":"Violence, Domestic","enrollment":2729},{"nctId":"NCT04386707","phase":"PHASE3","title":"Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2020-05-11","conditions":"Poliomyelitis","enrollment":1300},{"nctId":"NCT03883932","phase":"NA","title":"Fatherhood Focused Family Violence Education Program","status":"COMPLETED","sponsor":"Yale University","startDate":"2018-09-01","conditions":"Domestic Violence","enrollment":30},{"nctId":"NCT02957747","phase":"NA","title":"Addressing the Health Concerns of VA Women With Sexual Trauma","status":"COMPLETED","sponsor":"VISN 17 Center of Excellence","startDate":"2017-06-12","conditions":"Stress Disorders, Post-Traumatic, Intimate Partner Violence, Alcohol-Related Disorders","enrollment":153},{"nctId":"NCT04638985","phase":"PHASE4","title":"Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR","status":"UNKNOWN","sponsor":"China National Biotec Group Company Limited","startDate":"2020-11-13","conditions":"Vaccine","enrollment":600},{"nctId":"NCT04636827","phase":"PHASE4","title":"Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA","status":"UNKNOWN","sponsor":"China National Biotec Group Company Limited","startDate":"2020-11-11","conditions":"Vaccination","enrollment":600},{"nctId":"NCT04171206","phase":"NA","title":"Free From Abuse: The Booster Project","status":"COMPLETED","sponsor":"University of Sheffield","startDate":"2019-12-01","conditions":"Violence, Gender-Based, Violence, Domestic","enrollment":148},{"nctId":"NCT04618783","phase":"NA","title":"Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2019-07-20","conditions":"Poliomyelitis","enrollment":250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Control IPV","genericName":"Control IPV","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Control IPV is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3. Used for Poliomyelitis prevention in infants and children.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}